FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 107 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $218,000 | -35.7% | 56,200 | 0.0% | 0.00% | – |
| Q2 2019 | $339,000 | -59.8% | 56,200 | -10.7% | 0.00% | -100.0% |
| Q1 2019 | $843,000 | +44.1% | 62,900 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $585,000 | -29.3% | 62,900 | +5.9% | 0.00% | 0.0% |
| Q3 2018 | $827,000 | -11.9% | 59,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $939,000 | -7.9% | 59,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,020,000 | -3.5% | 59,400 | +23.2% | 0.00% | 0.0% |
| Q4 2017 | $1,057,000 | -46.4% | 48,200 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,972,000 | +35.9% | 48,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,451,000 | -4.2% | 48,200 | +15.0% | 0.00% | 0.0% |
| Q1 2017 | $1,515,000 | -27.9% | 41,900 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $2,100,000 | +0.3% | 41,900 | +5.0% | 0.00% | 0.0% |
| Q3 2016 | $2,094,000 | +23.5% | 39,900 | -2.7% | 0.00% | 0.0% |
| Q2 2016 | $1,695,000 | +24.8% | 41,000 | +18.5% | 0.00% | +50.0% |
| Q1 2016 | $1,358,000 | +23.5% | 34,600 | +30.6% | 0.00% | -33.3% |
| Q4 2015 | $1,100,000 | +169.6% | 26,500 | 0.0% | 0.00% | +200.0% |
| Q3 2015 | $408,000 | -29.2% | 26,500 | +14.2% | 0.00% | 0.0% |
| Q2 2015 | $576,000 | – | 23,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|